Can quality of life be quantified?

Clinical and Experimental Allergy Reviews

Volumn 2, Issue 2, 2002, Pages 57-60

  Juniper, Elizabeth F ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC RHINITIS; HUMAN; MEDICAL ETHICS; MORBIDITY; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RISK FACTOR;

EID: 0142091793     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2002.00037.x     Document Type: Review

References (28)

1. Guyatt GH, Naylor CD, Juniper EF, Heyland DK, Jaeschke R, Cook DJ for the Evidence-Based Medicine Working group. Users' guides to the medical literature. XII How to use articles about health-related quality of life. JAMA 1997; 277:1232-37.
2. Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991; 46:895-901.
3. Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In: Spilker B, eds. Quality of life assessment in clinical trials. New York: Raven Press, 1990:11-24.
4. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994; 94:182-8.
5. Bousquet J, Knani J, Dhivert H et al. Quality of life in asthma. I. Reliability and validity of the SF-36 Questionnaire. Am J Respir Crit Care Med 1994; 149:371-5.
6. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exper Allergy 1991; 21:77-83.
7. Marshall PS, Colon EA. Effects of allergy season on mood and cognitive function. Ann Allergy 1993; 71:251-8.
8. Gauci M, King MG, Saxarra H, Tulloch BJ, Husband AJ. A Minnesota Multiphasic Personality Inventory Profile of a woman with allergic rhinitis. Psychosom Med 1993; 55:533-40.
9. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994; 93:413-23.
10. Juniper EF, Rowland WC, Roberts NB, Thompson AK, King DR. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998; 101:163-70.
11. De Graaf-in 't Veld T, Koenders S, Garrelds IM, Gerth van Wijk R. Relationship between nasal hyperreactivity, quality of life and nasal symptoms in perennial rhinitis. J Allergy Clin Immunol 1996; 98:508-13.
12. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econom 1986; 5:1-30.
13. Kaplan RM, Anderson JP, Wu AW, Matthews WC, Kozin F, Orenstein D. The Quality of Well-being Scale: application in AIDS, cystic fibrosis and arthritis. Med Care 1989; 27:527-43.
14. Feeny D, Furlong W, Barr RD, Torrance GW, Rosenbaum P, Weitzman S. A comprehensive multi-attribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol 1992; 10:923-8.
15. The EuroQol Group. A new facility for the measurement of health-related quality of life. Health Policy 1990; 16:199-208.
16. Juniper EF, Thompson AK, Roberts JN. Can the Standard Gamble and Rating Scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36. Allergy 2002; 57:201-6.
17. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile. Development and final revision of a health status measure. Med Care 1981; 19:787-805.
18. Stewart AL, Hays R, Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988; 26:724-32.
19. Nelson E, Wasson J, Kirk J et al. Assessment of function in routine clinical practice: description of the COOP chart method and preliminary findings. J Chron Dis 1987; 40 (Suppl 1):S55.
20. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardised version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999; 104:364-9.
21. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000; 30:132-40.
22. Juniper EF. Quality of life questionnaires: does statistically significant = clinically important? J Allergy Clin Immunol 1998; 102:16-7. (Editorial).
23. Lydick E, Epstein RS. Interpretation of quality of life changes. Qual Life Res 1993; 2:221-6.
24. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47:81-7.
25. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996; 98:843-5.
26. Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomised trials. Br Med J 1998; 316:690-3.
27. Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet L-P, Haukioja A. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med 1995; 151:66-70.
28. van Cauwenberge P, Juniper EF and the STAR Study Investigating Group. Comparison of the efficacy, safety and QOL provided by fexofenadine hydrochloride 120mg, loratadine 10mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy 2000; 30:891-9.